• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Astria Therapeutics, Inc. - Common Stock (NQ:ATXS)

    12.59 +0.08 (+0.64%)
    Streaming Delayed Price Updated: 1:27 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Astria Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
    From Astria Therapeutics, Inc.
    Via Business Wire
    HALPER SADEH LLC ENCOURAGES PLYM, HOLX, ATXS, PCH SHAREHOLDERS to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play
    Via Stocktwits
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Unusual volume stocks in Monday's session
    In today's session, these stocks are experiencing unusual volume. 
    Via Chartmill
    SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates RYN, PCH, ATXS on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    BioCryst To Acquire Astria Therapeutics In $700M Deal
    Via Stocktwits
    Astria Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
     
    Via Benzinga
    SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ATXS and RYN on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate'
    BioCryst will acquire Astria Therapeutics for $700 million to expand its HAE portfolio with navenibart, aiming for double-digit revenue growth. 
    Via Benzinga
    Which stocks are gapping on Tuesday?
    Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
    Via Chartmill
    Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday
     
    Via Benzinga
    Which stocks are moving before the opening bell on Tuesday?
    As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
    Via Chartmill
    ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025
    From Astria Therapeutics, Inc.
    Via Business Wire
    Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference
    From Astria Therapeutics, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.